Head of Portfolio Management
AiCuris Anti-Infective Cures AG
Wuppertal, Nordrhein-Westfalen, Germany
Alexander Birkmann holds a PhD in biology and has more than 20 years of experience in the pharmaceutical industry. He has held various positions in drug research and development at both Bayer and AiCuris. He served as a project leader responsible for leading the development of pritelivir from preclinical stage to Phase 2. As Head of Research, he oversaw bacteriology and virology research. Since August 2023, Alexander has taken on a new role as the Head of Project, Portfolio Management and Strategy at AiCuris.
Disclosure(s): AiCuris Anti-Infective Cures AG: I am an employee of AiCuris, the company that develops pritelivir, and contributed to patents through AiCuris. (Ongoing)
Saturday, October 14, 2023
8:12 AM – 8:24 AM US ET